Laboratory variables and stratification of metastatic colorectal cancer patients: recommendations for therapeutic trials and for clinical practice guidelines
- 1 July 2004
- journal article
- review article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 345 (1-2), 1-15
- https://doi.org/10.1016/j.cccn.2004.02.017
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Systematic reviews in laboratory medicine: principles, processes and practical considerationsClinica Chimica Acta; International Journal of Clinical Chemistry, 2004
- Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patientsAnnals Of Oncology, 2002
- Carcinoembryonic antigen as an independent prognostic factor of recurrence and survival in patients resected for colorectal liver metastasesDiseases of the Colon & Rectum, 2001
- The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and ElaborationAnnals of Internal Medicine, 2001
- The Science of Systematic Reviewing Studies of Diagnostic Testscclm, 2000
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996
- The future of prognostic factors in outcome prediction for patients with cancerCancer, 1992
- Prognostic factors of advanced colorectal cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1986
- Multivariate Analysis of a Personal Series of 247 Patients with Liver Metastases from Colorectal CancerAnnals of Surgery, 1984